by Elisa Cascade; Amir H. Kalali, MD; and Uriel Halbreich, MD Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader
by Elisa Cascade and Amir H. Kalali, MD Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; and Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles
by Elisa Cascade; Amir H. Kalali, MD; and Richard H. Weisler, MD Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group
by Steven D. Targum, MD, and Alan J. Milbauer, RPh, JD Dr. Targum is an executive-in-residence at Oxford BioScience Partners and on the faculty of the Department of Psychiatry at
by Elisa Cascade; Amir H. Kalali, MD; and Richard H. Weisler, MD Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group
by David Feifel, MD, PhD Dr. Feifel is Associate Professor In Residence, Department of Psychiatry; Director, Neuropsychiatry and Behavioral Medicine Program; Director, UCSD Adult ADHD Program, University of California, San
by Elisa F. Cascade and Amir H. Kalali, MD Ms. Cascade is Vice President, Strategic Research and Safety, Quintiles Inc., Falls Church, Virginia; and Dr. Kalali is Vice President, Global
by Elisa Cascade; Amir H. Kalali, MD; Richard H. Weisler, MD; and Susan Lenderts Ms. Cascade is Vice President, Strategic Research and Safety, Quintiles Inc., Falls Church, Virginia; Dr. Kalali
by Randy A. Sansone, MD; Lori A. Sansone, MD Dr. R. Sansone is a Professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine
by Andrew A. Nierenberg, MD; and Steven D. Targum, MD Dr. Targum is on the editorial board of Psychiatry 2007. Presently, he is Chief Medical Officer at Brain Cells Inc.,
